Richard Ruedy - 02 Mar 2023 Form 4 Insider Report for Silk Road Medical Inc

Role
EVPClin&Reg.Affairs&QA
Signature
/s/Mhairi Jones, by power of attorney
Issuer symbol
N/A
Transactions as of
02 Mar 2023
Net transactions value
-$113,257
Form type
4
Filing time
06 Mar 2023, 19:20:33 UTC
Previous filing
04 Mar 2022
Next filing
15 Sep 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Award $0 +13,341 +9.9% $0.000000 147,856 02 Mar 2023 Direct F1
transaction SILK Common Stock Sale $113,257 -2,373 -1.6% $47.73 145,483 06 Mar 2023 Direct F2
holding SILK Common Stock 70 02 Mar 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are represented by restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of SILK common stock. 25% of the shares shall vest on March 1, 2024 and each one-year anniversary thereafter, subject to the Reporting Person continuing as a service provider through each such date.
F2 Represents shares that have been sold by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.